Abstract:AIMS:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel virus belonging to the Coronaviridae family that causes coronavirus disease (COVID-19). This disease rapidly reached pandemic status, presenting a serious threat to global health. However, the detailed molecular mechanism contributing to COVID-19 has not yet been elucidated.METHODS:The expression profiles, including the mRNA levels, of samples from patients infected with SARS-CoV-2 along with clinical data were obtained from the GSE152075 dataset in the Gene Expression Omnibus (GEO) database. Weighted gene co-expression network analysis (WGCNA) was used to identify co-expression modules, which were then implemented to evaluate the relationships between fundamental modules and clinical traits. The differentially expressed genes (DEGs), gene ontology (GO) functional enrichment, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway were evaluated using R software packages.RESULTS:A total of 377 SARS-CoV-2-infected samples and 54 normal samples with available clinical and genetic data were obtained from the GEO database. There were 1444 DEGs identified between the sample types, which were used to screen out 11 co-expression modules in the WGCNA. Six co-expression modules were significantly associated with three clinical traits (SARS-CoV-2 positivity, age, and sex). Among the DEGs in two modules significantly correlated with SARS-CoV-2 positivity, enrichment was observed in the biological process of viral infection strategies (viral translation) in the GO analysis. The KEGG signalling pathway analysis demonstrated that the DEGs in the two modules were commonly enriched in oxidative phosphorylation, ribosome, and thermogenesis pathways. Moreover, a five-core gene set (RPL35A, RPL7A, RPS15, RPS20, and RPL17) with top connectivity with other genes was identified in the SARS-CoV-2 infection modules, suggesting that these genes may be indispensable in viral transcription after infection.CONCLUSION:The identified core genes and signalling pathways associated with SARS-CoV-2 infection can significantly supplement the current understanding of COVID-19. The five core genes encoding ribosomal proteins may be indispensable in viral protein biosynthesis after SARS-CoV-2 infection and serve as therapeutic targets for COVID-19 treatment. These findings can be used as a basis for creating a hypothetical model for future experimental studies regarding associations of SARS-CoV-2 infection with ribosomal protein function.

Human genetic basis of severe or critical illness in COVID-19

Potential Core Genes Associated with COVID-19 Identified Via Weighted Gene Co-Expression Network Analysis.

Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility

Host Genetic Factors, Comorbidities and the Risk of Severe COVID-19

Mapping the human genetic architecture of COVID-19

Genome-wide association study of COVID-19 severity among the Chinese population

Genetic mechanisms of critical illness in Covid-19

Whole-genome sequencing reveals host factors underlying critical COVID-19

The Genetic Risk for COVID-19 Severity Is Associated With Defective Immune Responses

Targeted screening of genetic associations with COVID-19 susceptibility and severity

Single cell sequencing analysis uncovers genetics-influenced CD16+monocytes and memory CD8+T cells involved in severe COVID-19

An overview of human proteins and genes involved in SARS-CoV-2 infection

Genetic and Epigenetic Determinants of COVID-19 Susceptibility: A Systematic Review

Human Genetic Variants Associated with COVID-19 Severity Are Enriched in Immune and Epithelium Regulatory Networks

GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

Trans-ethnic genome-wide association study of severe COVID-19

The Covid-19 Pandemic From A Human Genetic Perspective

Genetic association of COVID-19 severe versus non-severe cases by RNA sequencing in patients hospitalised in Hong Kong

Immunological determinants of clinical outcomes in COVID-19: A quantitative perspective

Genetic variation analyses indicate conserved SARS‐CoV‐2–host interaction and varied genetic adaptation in immune response factors in modern human evolution

Computational Network Analysis of Host Genetic Risk Variants of Severe COVID-19